Search This Blog

Saturday, April 25, 2026

Medtronic's Sphere-9 catheter for ventricular tachycardia wins FDA Breakthrough Device

 

Medtronic's Sphere-9 catheter for ventricular tachycardia wins FDA Breakthrough Device status and pivotal U.S. trial approval

  • Interim six‑month study results for the Sphere-9 catheter showed positive outcomes in treating ventricular tachycardia.
  • Medtronic also reported new milestones in its Affera program related to the Sphere-9 ventricular tachycardia treatment platform.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)